CN102336739B - 一种氯雷他定化合物及其制法 - Google Patents
一种氯雷他定化合物及其制法 Download PDFInfo
- Publication number
- CN102336739B CN102336739B CN 201110197487 CN201110197487A CN102336739B CN 102336739 B CN102336739 B CN 102336739B CN 201110197487 CN201110197487 CN 201110197487 CN 201110197487 A CN201110197487 A CN 201110197487A CN 102336739 B CN102336739 B CN 102336739B
- Authority
- CN
- China
- Prior art keywords
- loratadine
- making
- purified
- purity
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110197487 CN102336739B (zh) | 2011-07-15 | 2011-07-15 | 一种氯雷他定化合物及其制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110197487 CN102336739B (zh) | 2011-07-15 | 2011-07-15 | 一种氯雷他定化合物及其制法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102336739A CN102336739A (zh) | 2012-02-01 |
CN102336739B true CN102336739B (zh) | 2012-09-26 |
Family
ID=45512735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110197487 Expired - Fee Related CN102336739B (zh) | 2011-07-15 | 2011-07-15 | 一种氯雷他定化合物及其制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102336739B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015084693A2 (en) * | 2013-12-05 | 2015-06-11 | Merck Sharp & Dohme Corp. | New process for preparing loratadine from a ketone intermediate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004080997A1 (en) * | 2003-03-13 | 2004-09-23 | Morepen Laboratories Limited | Process for the preparation of loratadine |
WO2006006184A2 (en) * | 2004-07-08 | 2006-01-19 | Morepen Laboratories Limited | A process for the manufacturing of loratadine and its intermediates |
-
2011
- 2011-07-15 CN CN 201110197487 patent/CN102336739B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004080997A1 (en) * | 2003-03-13 | 2004-09-23 | Morepen Laboratories Limited | Process for the preparation of loratadine |
WO2006006184A2 (en) * | 2004-07-08 | 2006-01-19 | Morepen Laboratories Limited | A process for the manufacturing of loratadine and its intermediates |
Also Published As
Publication number | Publication date |
---|---|
CN102336739A (zh) | 2012-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102093302B (zh) | 缬沙坦化合物及其制法 | |
CN102516096B (zh) | 一种盐酸氨溴索化合物的精制法 | |
CN102336739B (zh) | 一种氯雷他定化合物及其制法 | |
CN102010454B (zh) | 一种胞磷胆碱钠化合物及其新方法 | |
CN101824018A (zh) | 一种二氢杨梅素的纯化方法 | |
CN102351847B (zh) | 一种工业化的埃索美拉唑钠盐的精制方法 | |
CN102086196B (zh) | 一种氨曲南的方法 | |
CN102079721B (zh) | 一种托拉塞米化合物及其制法 | |
CN106608853B (zh) | 二肽基肽酶ⅳ抑制剂的制备方法 | |
CN104231044B (zh) | 那西肽过柱纯化工艺 | |
CN102702181A (zh) | 一种拉呋替丁化合物及其新制法 | |
CN103044369A (zh) | 一种盐酸决奈达隆的精制方法 | |
CN102321029B (zh) | 一种奥硝唑化合物及其新制法 | |
CN102367250B (zh) | 一种兰索拉唑化合物及其制法 | |
CN102491940B (zh) | 尼索地平化合物的制法 | |
CN102093297B (zh) | 替米沙坦化合物及其制法 | |
CN101560235B (zh) | 腺苷酸的精制方法 | |
CN102603709A (zh) | 一种硫辛酸化合物及其制法 | |
CN106083892A (zh) | 高纯度他克莫司化合物及其制备方法 | |
CN102492020A (zh) | 一种匹多莫德化合物及其新制法 | |
CN101033232B (zh) | 一种制备奥兰扎平晶型ⅰ的方法 | |
CN109400606B (zh) | 一种从阿哌沙班粗品中精制阿哌沙班的方法 | |
CN106749252B (zh) | 一种恩替卡韦中间体n8的提纯方法 | |
CN106565598A (zh) | 一种维生素b6结晶母液的回收方法 | |
CN102432562B (zh) | 一种富马酸喹硫平化合物及其新制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HAINAN LIONCO PHARMACEUTICAL GROUP CO., LTD. Effective date: 20130926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: HAINAN LIONCO PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 570216 No. 8 workshop, Haikou Free Trade Zone, Hainan Patentee after: Hainan Ling Kang Pharmaceutical Group Limited by Share Ltd. Address before: 570216 No. 8 workshop, Haikou Free Trade Zone, Hainan Patentee before: Hainan Lingkang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130926 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co.,Ltd. Address before: 570216 No. 8 workshop, Haikou Free Trade Zone, Hainan Patentee before: Hainan Ling Kang Pharmaceutical Group Limited by Share Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120926 Termination date: 20160715 |
|
CF01 | Termination of patent right due to non-payment of annual fee |